Literature DB >> 32093854

Tocilizumab for Fulminant Programmed Death 1 Inhibitor-Associated Myocarditis.

Hanping Wang1, Ran Tian2, Peng Gao2, Qian Wang3, Li Zhang4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32093854     DOI： 10.1016/j.jtho.2019.09.080

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  5 in total

Review 1.  TNF-α Inhibitors and Other Biologic Agents for the Treatment of Immune Checkpoint Inhibitor-Induced Myocarditis.

Authors:  Xiaohang Liu; Wei Wu; Ligang Fang; Yingxian Liu; Wei Chen
Journal:  Front Immunol       Date:  2022-07-01       Impact factor: 8.786

2.  Intensified immunosuppressive therapy in patients with immune checkpoint inhibitor-induced myocarditis.

Authors:  Jennifer Cautela; Sarah Zeriouh; Melanie Gaubert; Laurent Bonello; Marc Laine; Michael Peyrol; Franck Paganelli; Nathalie Lalevee; Fabrice Barlesi; Franck Thuny
Journal:  J Immunother Cancer       Date:  2020-12       Impact factor: 13.751

3.  Soluble programmed cell death-ligand 1 as a new potential biomarker associated with acute coronary syndrome.

Authors:  Shuping Li; Ling Yi; Xiqing Wei; Jinguo Zhang; Xiaojue Wang; Chang Jiang; Zhuohong Yan; Liwei Song; Bin Yang; Panjian Wei; Xiang Gao; Jinghui Wang; Hongtao Zhang; Jian Zhang
Journal:  Front Cardiovasc Med       Date:  2022-09-02

4.  Case Report: Treatment for steroid-refractory immune-related myocarditis with tofacitinib.

Authors:  Qian Xing; Zhongwei Zhang; Biao Zhu; Qionghua Lin; Lihua Shen; Fangfang Li; Zhili Xia; Zhiyong Zhao
Journal:  Front Immunol       Date:  2022-09-15       Impact factor: 8.786

Review 5.  Immune checkpoint inhibitor-induced myocarditis in cancer patients: a case report and review of reported cases.

Authors:  Emma Matzen; Lars Erik Bartels; Brian Løgstrup; Stine Horskær; Christina Stilling; Frede Donskov
Journal:  Cardiooncology       Date:  2021-08-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.